{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:30:30Z","timestamp":1788420630753,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanmic.2026.101451","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:46:33Z","timestamp":1788378393000},"page":"101451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Accelerating the clinical development of treatments for dengue: WHO dengue therapeutics landscape analysis and target product profiles"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-6975","authenticated-orcid":false,"given":"Xin Hui S","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-0449","authenticated-orcid":false,"given":"Gathsaurie Neelika","family":"Malavige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazle Rabbi","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora C","family":"de Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madiha","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Trieu","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3876-2209","authenticated-orcid":false,"given":"Jenny G","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq A","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Thisyakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L","family":"Valderrama-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet V","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasee","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Penazzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana P","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101451_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(23)02576-X","article-title":"Dengue","volume":"403","author":"Paz-Bailey","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2026.101451_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107940","article-title":"Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024","volume":"158","author":"Haider","year":"2025","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102943","article-title":"Global, regional, and national burden of dengue infection in children and adolescents: an analysis of the Global Burden of Disease Study 2021","volume":"78","author":"Deng","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lanmic.2026.101451_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14787210.2017.1358610","article-title":"Dengue in the elderly: a review","volume":"15","author":"Lin","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lanmic.2026.101451_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/tmi.13783","article-title":"Maternal and foetal-neonatal outcomes of dengue virus infection during pregnancy","volume":"27","author":"Rathore","year":"2022","journal-title":"Tropical Med Int Health"},{"key":"10.1016\/j.lanmic.2026.101451_bib7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","article-title":"Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis","volume":"21","author":"Sangkaew","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012217","article-title":"Diabetes mellitus as a risk factor for severe dengue fever and West Nile fever: a meta-analysis","volume":"18","author":"Lu","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14400","article-title":"A scoping review of arthropod-borne flavivirus infections in solid organ transplant recipients","volume":"26","author":"Im","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf093","article-title":"Dengue among immunocompromised patients: a systematic review and meta-analysis","volume":"32","author":"Cowan","year":"2025","journal-title":"J Travel Med"},{"key":"10.1016\/j.lanmic.2026.101451_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.lanmic.2026.101451_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.lanmic.2026.101451_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.1988.38.172","article-title":"A prospective study of dengue infections in Bangkok","volume":"38","author":"Burke","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanmic.2026.101451_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2026.101466","article-title":"WHO target product profiles for dengue therapeutics: an interdisciplinary analysis of ethical, regulatory, and implementation considerations","author":"Johnson","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101451_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.lanmic.2026.101451_bib40","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a first-in-class pan-serotype dengue virus NS4B inhibitor","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.lanmic.2026.101451_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/ciad284","article-title":"Safety, tolerability, and pharmacokinetics of JNJ-1802, a pan-serotype dengue direct antiviral small molecule, in a phase 1, double-blind, randomized, dose-escalation study in healthy volunteers","volume":"77","author":"Ackaert","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cpdd.1574","article-title":"Pharmacokinetics, safety, and tolerability of different maintenance dose regimens of Mosnodenvir (JNJ-1802) in healthy adult participants","volume":"14","author":"Kakuda","year":"2025","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.lanmic.2026.101451_bib43","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2500179","article-title":"Daily Mosnodenvir as dengue prophylaxis in a controlled human infection model","volume":"393","author":"Durbin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101451_bib44","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2026.101451_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006209","article-title":"Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein","volume":"12","author":"Budigi","year":"2018","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","article-title":"Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates","volume":"144","author":"Ong","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.lanmic.2026.101451_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1473-3099(24)00030-6","article-title":"An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia","volume":"24","author":"Gunale","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib49","series-title":"Healthy volunteers","article-title":"A study to determine the safety of AV-1, an antibody being developed for treatment of dengue","year":"2022"},{"key":"10.1016\/j.lanmic.2026.101451_bib54","article-title":"Island enrols first subjects for phase 2b clinical trial for dengue fever drug","author":"Smith","year":"2025","journal-title":"Hot Copper"},{"key":"10.1016\/j.lanmic.2026.101451_bib56","series-title":"Patients with dengue fever","article-title":"A study to assess the efficacy, safety and pharmacokinetics of EYU688","year":"2023"},{"key":"10.1016\/j.lanmic.2026.101451_bib57","article-title":"A study to evaluate the safety and efficacy of AV-1 against dengue virus 3 (DENV-3)","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.lanmic.2026.101451_bib60","series-title":"Participants with confirmed dengue fever","article-title":"A study of JNJ-64281802","year":"2024"},{"key":"10.1016\/j.lanmic.2026.101451_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(90)90029-7","article-title":"Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys","volume":"13","author":"Malinoski","year":"1990","journal-title":"Antivir Res"},{"key":"10.1016\/j.lanmic.2026.101451_bib29","article-title":"Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients\u2013a phase II randomized controlled clinical trial","volume":"29\u201330","author":"Chakraborty","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.lanmic.2026.101451_bib32","first-page":"1115","article-title":"Montelukast reduces the risk of dengue shock syndrome in dengue patients","volume":"35","author":"Ahmad","year":"2018","journal-title":"Trop Biomed"},{"key":"10.1016\/j.lanmic.2026.101451_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011927","article-title":"Effect of montelukast in preventing dengue with warning signs among patients with dengue: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"18","author":"Nitinai","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010123","article-title":"Efficacy of Rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: a randomised, double blind, placebo-controlled trial","volume":"16","author":"Malavige","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib35","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/s41598-018-22285-x","article-title":"A preliminary study on efficacy of Rupatadine for the treatment of acute dengue infection","volume":"8","author":"Malavige","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanmic.2026.101451_bib61","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib64","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101451_bib72","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1038\/s41598-025-91099-5","article-title":"Kinetics of NS1 and anti-NS1 IgG following dengue infection reveals likely early formation of immune complexes in secondary infected patients","volume":"15","author":"Muller","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanmic.2026.101451_bib73","article-title":"Evaluation of rapid diagnostic tests to detect dengue virus infections in Taiwan","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101451_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101088","article-title":"Evaluating the performance of common reference laboratory tests for acute dengue diagnosis: a systematic review and meta-analysis of RT-PCR, NS1 ELISA, and IgM ELISA","volume":"6","author":"Pillay","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101451_bib76","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1016\/S2214-109X(24)00512-6","article-title":"Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation","volume":"13","author":"Dey","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanmic.2026.101451_bib77","series-title":"Council for International Organizations of Medical Sciences (CIOMS)","year":"2016"},{"key":"10.1016\/j.lanmic.2026.101451_bib78","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1475-6773.2005.0k375.x","article-title":"Commentary--goodbye M(C)ID! Hello MID, where do you come from?","volume":"40","author":"Sch\u00fcnemann","year":"2005","journal-title":"Health Serv Res"},{"key":"10.1016\/j.lanmic.2026.101451_bib82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2352-4642(25)00040-9","article-title":"Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network","volume":"9","author":"Penazzato","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.lanmic.2026.101451_bib83","article-title":"Defining the concept of fair pricing for medicines","volume":"368","author":"Moon","year":"2020","journal-title":"BMJ"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:46:39Z","timestamp":1788378399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S2666524726001060"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101451","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerating the clinical development of treatments for dengue: WHO dengue therapeutics landscape analysis and target product profiles","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101466","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101451"}}